Krsnaa Diagnostics: 30-35% revenue CAGR for FY23-25 at a PE of 35
www.moneymuscle.in
After a weak FY24 guidance in Q4-23, KRSNAA gave a strong guidance for FY24 in Q1-24. Change shows the confidence the management has about its prospects & creates opportunities in the stock.
Krsnaa Diagnostics: 30-35% revenue CAGR for FY23-25 at a PE of 35
Krsnaa Diagnostics: 30-35% revenue CAGR for…
Krsnaa Diagnostics: 30-35% revenue CAGR for FY23-25 at a PE of 35
After a weak FY24 guidance in Q4-23, KRSNAA gave a strong guidance for FY24 in Q1-24. Change shows the confidence the management has about its prospects & creates opportunities in the stock.